Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026014
Filing Date
2021-11-10
Accepted
2021-11-10 08:02:25
Documents
52
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20210930_10q.htm   iXBRL 10-Q 687963
2 EXHIBIT 31.1 ex_303333.htm EX-31.1 9016
3 EXHIBIT 31.2 ex_303334.htm EX-31.2 8920
4 EXHIBIT 32.1 ex_303335.htm EX-32.1 4869
5 EXHIBIT 32.2 ex_303336.htm EX-32.2 5260
11 dffn20210930_10qimg001.gif GRAPHIC 3024
12 dffn20210930_10qimg002.gif GRAPHIC 10258
  Complete submission text file 0001437749-21-026014.txt   3319878

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dffn-20210930.xsd EX-101.SCH 34059
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20210930_cal.xml EX-101.CAL 25066
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20210930_def.xml EX-101.DEF 214117
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20210930_lab.xml EX-101.LAB 213771
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20210930_pre.xml EX-101.PRE 236165
13 EXTRACTED XBRL INSTANCE DOCUMENT dffn20210930_10q_htm.xml XML 407506
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 211394495
SIC: 2834 Pharmaceutical Preparations